https://www.selleckchem.com/products/k02288.html
Controlled reoxygenation on starting cardiopulmonary bypass (CP rather than hyperoxic CPB may confer clinical advantages during surgery for congenital cyanotic heart disease. A single-centre, randomized controlled trial was carried out to compare the effectiveness of controlled reoxygenation (normoxia) versus hyperoxic CPB in children with congenital cyanotic heart disease undergoing open-heart surgery (Oxic-2). The co-primary clinical outcomes were duration of inotropic support, intubation time and postoperative intensive care unit (I